Pediatric and Developmental Pharmacology for Inflammatory and Infectious Diseases

炎症和传染病的儿科和发育药理学

基本信息

项目摘要

Administrative Core Abstract The Administrative Core supports the program entitled “Pediatric and Developmental Pharmacology for Inflammatory and Infectious Diseases” as a Specialized Center in Research in Pediatric Developmental Pharmacology (RPDP) Program (U54) at UC San Diego. The goal of the Administrative Core is to make certain that the entire UC San Diego RPDP program functions as efficiently and optimally as possible via the following aims. In Aim 1, the Core will promote communication and overall cohesiveness among the various elements of the UC San Diego RPDP Center to ensure efficient operations. To that end, the Administrative Core will focus on organizing its group meetings, retreats, and journal clubs, and by addressing and solving any and all institutional issues that arise. In Aim 2, the Core will track the financial status of the UC San Diego RPDP Center and coordinate report generations for the IRB, FDA and NIH. In Aim 3 the Core will provide ongoing critical evaluation and outcomes assessment to achieve continual improvement of RPDP effectiveness by organizing independent external as well as internal reviews of the program. The Scientific Advisory Committee will serve a key role as its members evaluate the RPDP Center and lend their expertise to promote scientific progress. In Aim 4 the Core will promote the integration of cross-disciplinary research and will serve as point of contact for outside entities seeking to collaborate with the RPDP, including the NICHD, other NICHD-supported Pediatric Pharmacology Training (T32) Programs, other RPDP Centers and industry. Through Aim 5 the Core will coordinate the pilot project application process and monitor project execution and outcomes. With Aim 6 the Administrative Core will support the quantitative pharmacokinetic and pharmacodynamics (PK/PD) modeling needs of the Projects and provide timely, accurate, and cost effective quantitative assays in support of the analytical needs of the Projects through the establishment of a Clinical Pharmacology Section under the leadership of Dr. Edmund Capparelli, a leader in the field of pediatric PK/PD modeling. Through Aim 7 the Administrative Core will seek to continue the excellent track record of the UC San Diego RPDP in training pediatric clinical pharmacologists through a Training and Outreach Section, lead by Dr. Adriana Tremoulet, co-PI of a recently awarded NICHD-funded T32 in Clinical Pharmacology. This Training and Outreach Section will provide an integrated educational and practical mentored research training experience in pediatric clinical pharmacology for health sciences professionals interested in becoming leaders in the field. This will serve as the platform for cross-training across the RPDP Centers as well. Efficient organization, administration and communication is essential for overall RPDP Center success especially given the translational nature of the research. Our success over the last five years as an RPDP Center demonstrates our ability to effectively administrate such a Center and demonstrates our ability to promote the successful interactions between clinical and basic science investigators to advance the field of pediatric pharmacology.
行政核心摘要 行政核心支持题为“儿童和发育药理学, 炎症和感染性疾病”作为一个专门的研究中心,在儿科发育 药理学(RPDP)项目(U 54)。行政核心的目标是使 确保整个UC San Diego RPDP计划通过 的目标。在目标1中,核心将促进各组织之间的沟通和整体凝聚力。 加州大学圣地亚哥分校RPDP中心的元素,以确保有效的运作。为此,行政 核心将专注于组织其小组会议,务虚会和期刊俱乐部,并通过解决和解决 任何出现的制度性问题在目标2中,核心将跟踪加州大学圣地亚哥分校的财务状况 RPDP中心并协调IRB、FDA和NIH的报告生成。在目标3中, 持续的关键评价和结果评估,以实现RPDP的持续改进 通过组织独立的外部和内部审查程序的有效性。科学 咨询委员会将在其成员评估RPDP中心并将其专业知识用于 推动科学进步。在目标4中,核心将促进跨学科研究的整合, 将作为寻求与RPDP合作的外部实体的联络点,包括NICHD, 其他NICHD支持的儿科药理学培训(T32)计划,其他RPDP中心和行业。 通过目标5,核心将协调试点项目的申请过程,并监测项目的执行情况, 结果。根据目标6,管理核心将支持定量药代动力学, 药物动力学(PK/PD)建模需求,并提供及时、准确和具有成本效益的 定量分析,通过建立一个临床 药理学部门在儿科领域的领导者Edmund Capparelli博士的领导下 PK/PD建模。通过目标7,行政核心将努力继续保持 加州大学圣地亚哥分校RPDP通过培训和外联科培训儿科临床药理学家, 由Adriana Tremoulet博士领导,他是最近获得NICHD资助临床药理学T32的共同PI。这 培训和外联科将提供综合的教育和实践指导研究培训 有兴趣成为领导者的健康科学专业人员的儿科临床药理学经验 在外地这也将作为跨RPDP中心的交叉培训平台。高效 组织、管理和沟通对于整个RPDP中心的成功至关重要,特别是考虑到 研究的翻译性质。我们在过去五年中作为RPDP中心的成功证明了 我们有能力有效地管理这样一个中心,并证明我们有能力促进成功的 临床和基础科学研究人员之间的互动,以推进儿科药理学领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADRIANA H TREMOULET其他文献

ADRIANA H TREMOULET的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADRIANA H TREMOULET', 18)}}的其他基金

Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses (mPRINT P50)
使用药物微生物组学和代谢组学分析优化母亲及其母乳喂养婴儿的抗生素 (mPRINT P50)
  • 批准号:
    10487509
  • 财政年份:
    2021
  • 资助金额:
    $ 27.23万
  • 项目类别:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses (mPRINT P50)
使用药物微生物组学和代谢组学分析优化母亲及其母乳喂养婴儿的抗生素 (mPRINT P50)
  • 批准号:
    10309712
  • 财政年份:
    2021
  • 资助金额:
    $ 27.23万
  • 项目类别:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses (mPRINT P50)
使用药物微生物组学和代谢组学分析优化母亲及其母乳喂养婴儿的抗生素 (mPRINT P50)
  • 批准号:
    10681302
  • 财政年份:
    2021
  • 资助金额:
    $ 27.23万
  • 项目类别:
Phase I and IIa trial of atorvastatin in children with acute Kawasaki disease
阿托伐他汀治疗急性川崎病儿童的 I 期和 IIa 期试验
  • 批准号:
    9096853
  • 财政年份:
    2014
  • 资助金额:
    $ 27.23万
  • 项目类别:
Phase I and IIa trial of atorvastatin in children with acute Kawasaki disease
阿托伐他汀治疗急性川崎病儿童的 I 期和 IIa 期试验
  • 批准号:
    9216033
  • 财政年份:
    2014
  • 资助金额:
    $ 27.23万
  • 项目类别:
Pharmacologic Determinants for Optimized Therapy in HIV-Infected Children
HIV 感染儿童优化治疗的药理学决定因素
  • 批准号:
    8123189
  • 财政年份:
    2007
  • 资助金额:
    $ 27.23万
  • 项目类别:
Pharmacologic Determinants for Optimized Therapy in HIV-Infected Children
HIV 感染儿童优化治疗的药理学决定因素
  • 批准号:
    7490096
  • 财政年份:
    2007
  • 资助金额:
    $ 27.23万
  • 项目类别:
Pharmacologic Determinants for Optimized Therapy in HIV-Infected Children
HIV 感染儿童优化治疗的药理学决定因素
  • 批准号:
    7673722
  • 财政年份:
    2007
  • 资助金额:
    $ 27.23万
  • 项目类别:
Pharmacologic Determinants for Optimized Therapy in HIV-Infected Children
HIV 感染儿童优化治疗的药理学决定因素
  • 批准号:
    7908694
  • 财政年份:
    2007
  • 资助金额:
    $ 27.23万
  • 项目类别:
Pharmacologic Determinants for Optimized Therapy in HIV-Infected Children
HIV 感染儿童优化治疗的药理学决定因素
  • 批准号:
    7338088
  • 财政年份:
    2007
  • 资助金额:
    $ 27.23万
  • 项目类别:

相似海外基金

EAGER: Toward a Decentralized Cross-administrator Zone Management System: Policy and Technology
EAGER:走向去中心化的跨管理员区域管理系统:政策和技术
  • 批准号:
    2331936
  • 财政年份:
    2023
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Standard Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
  • 批准号:
    2043230
  • 财政年份:
    2021
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Continuing Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
  • 批准号:
    2043334
  • 财政年份:
    2021
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Continuing Grant
Making of the base for patient safety management skill of visiting nurse administrator by the web conference system
利用网络会议系统构建出诊护士管理者患者安全管理技能基础
  • 批准号:
    19K10768
  • 财政年份:
    2019
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the nursing administrator training program to improve leadership behavior focused on emotional intelligence
制定护理管理人员培训计划,以改善以情商为重点的领导行为
  • 批准号:
    18K17464
  • 财政年份:
    2018
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Automated Network Management that Dynamically Reflects Administrator Intent
动态反映管理员意图的自动化网络管理
  • 批准号:
    18K18038
  • 财政年份:
    2018
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Administrator support perceived as useful for professional growth by novice psychiatric home-visit nursing staff
新手精神科家访护理人员认为管理员支持对专业成长有用
  • 批准号:
    17H07005
  • 财政年份:
    2017
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The Facts and Problems on Management of Public Museums: Validation of Designated Administrator System
公共博物馆管理的事实与问题:指定管理员制度的验证
  • 批准号:
    17K01212
  • 财政年份:
    2017
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study on Transformation of the School Administrator Preparation and Evaluation System in the United States
美国学校管理人员培养与评价体系转型研究
  • 批准号:
    26780449
  • 财政年份:
    2014
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The Family Court's Supervision of Property Administrator
家庭法院对财产管理人的监督
  • 批准号:
    26380108
  • 财政年份:
    2014
  • 资助金额:
    $ 27.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了